110 related articles for article (PubMed ID: 8364910)
21. Expression of chromogranin A mRNA in small cell carcinoma of the lung.
Hamid Q; Corrin B; Sheppard MN; Huttner WB; Polak JM
J Pathol; 1991 Apr; 163(4):293-7. PubMed ID: 1851827
[TBL] [Abstract][Full Text] [Related]
22. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
23. Expression of neuron-specific enolase, chromogranin A, synaptophysin and Leu-7 in lung cancer cell lines.
Poola I; Graziano SL
J Exp Clin Cancer Res; 1998 Jun; 17(2):165-73. PubMed ID: 9700577
[TBL] [Abstract][Full Text] [Related]
24. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.
Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM
Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916
[TBL] [Abstract][Full Text] [Related]
25. SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer.
Moss AC; Jacobson GM; Walker LE; Blake NW; Marshall E; Coulson JM
Clin Cancer Res; 2009 Jan; 15(1):274-83. PubMed ID: 19118055
[TBL] [Abstract][Full Text] [Related]
26. Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
Dobashi Y; Watanabe H; Sato Y; Hirashima S; Yanagawa T; Matsubara H; Ooi A
J Pathol; 2006 Dec; 210(4):431-40. PubMed ID: 17029220
[TBL] [Abstract][Full Text] [Related]
27. Lack of expression of P-glycoprotein in 7 small cell lung cancer cell lines established both from untreated and from treated patients.
Milroy R; Plumb JA; Batstone P; Maclay A; Wishart GC; Hay FG; Candlish W; Adamson R; Khan MZ; Banham S
Anticancer Res; 1992; 12(1):193-200. PubMed ID: 1348921
[TBL] [Abstract][Full Text] [Related]
28. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas.
Baylin SB; Höppener JW; de Bustros A; Steenbergh PH; Lips CJ; Nelkin BD
Cancer Res; 1986 Jun; 46(6):2917-22. PubMed ID: 3009002
[TBL] [Abstract][Full Text] [Related]
29. Biochemical characterization of peptide alpha-amidation enzyme activities of human neuroendocrine lung cancer cell lines.
Treston AM; Scott FM; Vos M; Iwai N; Mains RE; Eipper BA; Cuttitta F; Mulshine JL
Cell Growth Differ; 1993 Nov; 4(11):911-20. PubMed ID: 8297797
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of the promoter region of a neuroendocrine tumor marker, IA-1.
Li Q; Notkins AL; Lan MS
Biochem Biophys Res Commun; 1997 Jul; 236(3):776-81. PubMed ID: 9245732
[TBL] [Abstract][Full Text] [Related]
31. Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.
Oue N; Mitani Y; Aung PP; Sakakura C; Takeshima Y; Kaneko M; Noguchi T; Nakayama H; Yasui W
J Pathol; 2005 Oct; 207(2):185-98. PubMed ID: 16086444
[TBL] [Abstract][Full Text] [Related]
32. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.
Ohta Y; Endo Y; Tanaka M; Shimizu J; Oda M; Hayashi Y; Watanabe Y; Sasaki T
Clin Cancer Res; 1996 Aug; 2(8):1411-6. PubMed ID: 9816315
[TBL] [Abstract][Full Text] [Related]
33. Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma.
Ozaki Y; Kontani K; Hanaoka J; Chano T; Teramoto K; Tezuka N; Sawai S; Fujino S; Yoshiki T; Okabe H; Ohkubo I
Cancer; 2002 Nov; 95(9):1954-62. PubMed ID: 12404290
[TBL] [Abstract][Full Text] [Related]
34. Specific sensitivity of small cell lung cancer cell lines to the snake venom toxin taipoxin.
Poulsen TT; Pedersen N; Perin MS; Hansen CK; Poulsen HS
Lung Cancer; 2005 Dec; 50(3):329-37. PubMed ID: 16115696
[TBL] [Abstract][Full Text] [Related]
35. Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.
Lyda MH; Weiss LM
Hum Pathol; 2000 Aug; 31(8):980-7. PubMed ID: 10987260
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic relevance of overexpressed mRNA of novel oncogene with kinase-domain (NOK) in lung cancers.
Amachika T; Kobayashi D; Moriai R; Tsuji N; Watanabe N
Lung Cancer; 2007 Jun; 56(3):337-40. PubMed ID: 17298854
[TBL] [Abstract][Full Text] [Related]
38. [Mapping and expression analysis of a different expression cDNA fragment from lung adenocarcinoma cell line].
Fan H; Li Y; Feng HC; Lü BJ; Fu SB; Zhang GY; Li P
Yi Chuan Xue Bao; 2002 Jun; 29(6):476-80. PubMed ID: 12096622
[TBL] [Abstract][Full Text] [Related]
39. Interference with netrin-1 and tumor cell death in non-small cell lung cancer.
Delloye-Bourgeois C; Brambilla E; Coissieux MM; Guenebeaud C; Pedeux R; Firlej V; Cabon F; Brambilla C; Mehlen P; Bernet A
J Natl Cancer Inst; 2009 Feb; 101(4):237-47. PubMed ID: 19211441
[TBL] [Abstract][Full Text] [Related]
40. Chromogranin A, a significant prognostic factor in small cell lung cancer.
Drivsholm L; Paloheimo LI; Osterlind K
Br J Cancer; 1999 Oct; 81(4):667-71. PubMed ID: 10574253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
